No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 345 | 36,504 | 302 | 38,981 | 39,100 | 39,138 | N/A | N/A |
| Operating profit | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | $m | 51 | 4,959 | 4,370 | 4,316 | 2,804 | 1,520 | N/A | N/A |
| EPS reported | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | $m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | $ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | Locked | Locked | Locked |
| Environmental score | Locked | Locked | Locked |
| Social score | Locked | Locked | Locked |
| Governance score | Locked | Locked | Locked |
| Risk rating | Locked | Locked | Locked |
Company overview
Hogy Medical Co.,Ltd., along with its affiliated entities, operates within Japan, specializing in a diverse array of medical products. Their offerings encompass medical-grade and non-woven textiles, comprehensive surgical kits, and various other healthcare solutions. The company provides specialized kit solutions designed for surgical procedures, including integrated kits that cover the entire perioperative phase (before, during, and after surgery). Its non-woven product line features items like protective gowns, personal protective equipment (PPE), wearable medical garments, surgical drapes, pre-packaged sterile items, covers for instrument tables, and wraps. A notable non-woven innovation is Tigalyer, distinguished by its liquid barrier and waterproofing capabilities. Furthermore, Hogy Medical supplies a range of sterilization products, such as various hybrid Mekkin bags and autoclave forceps stands. To ensure sterilization efficacy, they offer detection cards like Mekkin cards for autoclave processes and ethylene oxide gas cards for EO gas sterilization, alongside indicator tapes for autoclave use. Beyond physical products, the company delivers advanced management systems, including Opera Master for surgical workflow optimization, a system for managing medical electronic (ME) equipment operations, and an automated drug reading and management system for narcotics and poisons, utilizing radio frequency identification (RFID) technology. Additional medical devices include endoscope holders and Securea, a specialized polyurethane sponge engineered for endoscopic surgical applications. Founded in 1961, the company, originally known as Hogy Co., Ltd., adopted its current name, Hogy Medical Co.,Ltd., in 1987. Its corporate headquarters are located in Tokyo, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Hogy Medical Co.,Ltd., along with its affiliated entities, operates within Japan, specializing in a diverse array of medical products. Their offerings encompass medical-grade and non-woven textiles, comprehensive surgical kits, and various other healthcare solutions. The company provides specialized kit solutions designed for surgical procedures, including integrated kits that cover the entire perioperative phase (before, during, and after surgery). Its non-woven product line features items like protective gowns, personal protective equipment (PPE), wearable medical garments, surgical drapes, pre-packaged sterile items, covers for instrument tables, and wraps. A notable non-woven innovation is Tigalyer, distinguished by its liquid barrier and waterproofing capabilities. Furthermore, Hogy Medical supplies a range of sterilization products, such as various hybrid Mekkin bags and autoclave forceps stands. To ensure sterilization efficacy, they offer detection cards like Mekkin cards for autoclave processes and ethylene oxide gas cards for EO gas sterilization, alongside indicator tapes for autoclave use. Beyond physical products, the company delivers advanced management systems, including Opera Master for surgical workflow optimization, a system for managing medical electronic (ME) equipment operations, and an automated drug reading and management system for narcotics and poisons, utilizing radio frequency identification (RFID) technology. Additional medical devices include endoscope holders and Securea, a specialized polyurethane sponge engineered for endoscopic surgical applications. Founded in 1961, the company, originally known as Hogy Co., Ltd., adopted its current name, Hogy Medical Co.,Ltd., in 1987. Its corporate headquarters are located in Tokyo, Japan.